Mutant p53 regulates reversible subtype plasticity in pancreatic cancer

突变型p53调控胰腺癌的可逆亚型可塑性

阅读:2
作者:June-Ha Shin,Hwa-Ryeon Kim,Jae-Seok Roe

Abstract

Loss-of-function mutations in the TP53 gene are the most frequent genetic events in human malignancies. However, the extent to which missense TP53 mutations confer oncogenic gain-of-function (GOF) properties remains incompletely understood. Using genetically defined pancreatic cancer organoid models, we demonstrated that mutant p53 provides a selective growth advantage under acute environmental stress and drives molecular transition toward a basal-like state. Transcriptomic analyses showed that under stress conditions, organoids expressing mutant p53 adopted a basal-like gene expression program, a characteristic of a poor prognosis subtype of pancreatic cancer. Furthermore, the molecular subtype was reversed to the classical subtype once it returned to normal growth conditions, suggesting that transcriptional plasticity arises from acute changes in the tissue microenvironment. Given these context-dependent oncogenic properties, our findings suggest that targeting mutant p53 may be a promising therapeutic strategy for pancreatic cancer. Supplementary Information: The online version contains supplementary material available at 10.1007/s00018-025-05945-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。